İntestinal Gaz ve Şişkinliğe Güncel Yaklaşım

Yıl 2017, Cilt: 5 Sayı: 2, 18 - 23, 05.02.2017

Dr. Hüseyin Savaş Göktürk

Öz

Öz

Klinik pratikte polikliniklere başvuran hastaların önemli bir kısmının yakınması intestinal gaz ve ilişkili yakınmalardır. Yapılan çalışmalarda bu oranın, kullanılan tanımlamalara ve araştırma yapılan popülasyona göre değişmekle birlikte, %20 ile %40 arasında olduğu bildirilmektedir. İntestinal gaz ve ilişkili belirti ve bulgular karmaşık mekanizmalar ile oluşan heterojen bir tablodur. Dikkatlice alınmış bir öykü sonrası yapılan fizik muayene ve çoğu zaman sınırlı tetkikler ile fonksiyonel ve organik nedenler birbirinden ayrılabilmektedir.  Henüz, tüm hastalarda etki eden ve genel kabul gören birtedavi yöntemi mevcut değildir. Hastanın yeterince bilgilendirilmesi tedavide önemli yertutmaktadır. Gerek farmakolojik tedavilerle gerekse de diyet ve yaşam tarzı değişiklikleri ile çeşitli derecelerde etkinlik elde edilebilmektedir.

Anahtar Kelimeler

İntestinal gaz, Şişkinlik, Abdominal distansiyon

Intestinal Gas and Bloating on Current Approaches

Öz

Abstract

Bloating is one of the most common gastrointestinal symptoms, which is a frequentcomplaint in the patients of all ages. In surveys of healthy individuals and populations 10–30% experience bloating often, frequently, or greater than a quarter of the time. Clinicians should consider a heterogeneous condition produced by a combination of various mechanisms. Careful history and physical examination with limited tests can help to differeantiate organic and functional causes easily. Currently, there is no treatmentwhich has indisputably proven to be effective for bloating. However, reassurance, education and a step-by-step therapeutic  approach involving diet and medications. 

Kaynakça

• Kaynaklar 1.Sullivan SN. Functional abdominal bloating with distention. ISRNGastroenterol. 2012;2012:721820. 2.Lacy BE, Gabbard SL, Crowell MD. Pathophysiology, evaluation,and treatment of bloating: hope, hype, or hot air? Gastroenterol He-patol (N Y). 2011;7(11):729-39. 3.Seo AY, Kim N, Oh DH. Abdominal bloating: pathophysiology andtreatment. J Neurogastroenterol Motil. 2013;19(4):433-53 4.Bolin T. Wind -- problems with intestinal gas. Aust Fam Physician.2013;42(5):280-3. 5.Gülşen M. Gastrointestinal Sitem ve Gaz. Güncel gastroenteroloji. 2010;14(4):202-210. 6.Scaldaferri F, Nardone O, Lopetuso LR, Petito V, Bibbò S, LaterzaL, et al. Intestinal gas production and gastrointestinal symptoms: frompathogenesis to clinical implication. Eur Rev Med Pharmacol Sci.2013;17 Suppl 2.2-10. 7.Bolin TD. Understanding gas and bloating: Why can’t I do my je-ans up at night? NSW: The Gut Foundation, 2011. 8.Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR,Stanghellini V. Functional gastroduodenal disorders. Gastroentero-logy. 2006;130(5):1466. 9.Bredenoord AJ, Weusten BL, Sifrim D, et al. Aerophagia, gastric,and supragastric belching: a study using intraluminal electrical im-pedance monitoring. Gut 2004;53,1561–1565. 10.Koukias N, Woodland P, Yazaki E, Sifrim D. Supragastric Belching:Prevalence and Association With Gastroesophageal Reflux Disea-se and Esophageal Hypomotility. J Neurogastroenterol Motil.2015;21(3):398-403 11.Bredenoord AJ, Weusten BL, Sifrim D, Timmer R, Smout AJ. Aerop-hagia, gastric, and supragastric belching: a study using intralumi-nal electrical impedance monitoring. Gut 2004;53.1561-1565 12.Hemmink GJ, Ten Cate L, Bredenoord AJ, et al. Speech therapy inpatients with excessive supragastric belching—a pilot study. Neu-rogastroenterol Motil 2010;22.24–28.e2–3. 13.Bredenoord AJ. Management of belching, hiccups, and aerophagia.Clin Gastroenterol Hepatol. 2013;11(1):6-12. 14.Blondeau K, Dupont L, Tack J, et al. Weakly acidic and non-acid gas-troesophageal reflux may induce chronic cough. Gastroenterology2004;126(Suppl 2):A99. 15.Páramo Hernández DB. Bloating and abdominal distention: Just gas?A look in the direction of physiology. Rev Col Gastroenterol2011;26.269-272. 16.Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F,Spiller RC. Functional bowel disorders. Gastroenterology2006;130:1480-1491. 17.Serra J. Intestinal gas: has diet anything to do in the absence of ademonstrable malabsorption state? Curr Opin Clin Nutr Metab Care2012; 15: 489-493. 18.Salvioli B, Serra J, Azpiroz F, Lorenzo C, Aguade S, Castell J, et al.Origin of gas retention and symptoms in patients with bloating. Gas-troenterology 2005; 128: 574-579. 19.Iovino P, Bucci C, Tremolaterra F, Santonicola A, Chiarioni G. Bloa-ting and functional gastro-intestinal disorders: Where are we andwhere are we going? World J Gastroenterol. 2014 October 21; 20(39):14407–14419 20.Coffin B, Bortolloti C, Bourgeois O, Denicourt L. Efficacy of a si-methicone, activated charcoal and magnesium oxide combination(Carbosymag®) in functional dyspepsia: results of a general prac-tice-based randomized trial. Clin Res Hepatol Gastroenterol 2011;35: 494-499. 21.Tack J, Broekaert D, Fischler B, Van Oudenhove L, Gevers AM, Jans-sens J. A controlled crossover study of the selective serotonin reup-take inhibitor citalopram in irritable bowel syndrome. Gut 2006; 55:1095-1103. 22.Schoenfeld P, Pimentel M, Chang L, Lembo A, Chey WD, Yu J, etal. Safety and tolerability of rifaximin for the treatment of irritablebowel syndrome without constipation: a pooled analysis of rando-mised, double-blind, placebo-controlled trials. Aliment PharmacolTher. 2014;39(10):1161-8. 23.Hungin AP, Mulligan C, Pot B, Whorwell P, Agréus L, Fracasso P,et al. Systematic review: probiotics in the management of lower gas-trointestinal symptoms in clinical practice -- an evidence-based in-ternational guide. Aliment Pharmacol Ther 2013; 38: 864-886.